Fact CheckerSign in

NCT05121064Completed

Common Elements Treatment Approach HIV Alcohol Reduction Trial in Zambia

Source: ClinicalTrials.gov · Last updated 1 Jul 2026

Brief summary (registry, in English)

This study, which is part of the Zambia Alabama HIV Alcohol Comorbidities Program funded by NIH-NIAAA, is designed to examine the efficacy of brief and in-depth cognitive behavioral therapy-based interventions to address, unhealthy alcohol use, comorbid mental health symptoms, and HIV treatment outcomes among people living with HIV in Zambia. A 3-arm trial will be conducted with participants randomized to a brief intervention alone, the brief intervention plus referral to Common Elements Treatment Approach (CETA), or standard of care (SOC).

Status (registry)
Completed
Study type
Interventional
Enrollment
680 (actual)
First submitted
12 Nov 2021
Start date
24 Jan 2023
Primary completion date
31 Oct 2025
Lead sponsor
University of Alabama at Birmingham
Diseases
HIV
NCT number
NCT05121064

What you commit to

  • Study type: Interventional
  • Participants enrolled: 680
  • From 24 Jan 2023 to the primary completion date, 31 Oct 2025
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Plan to relocate out of Lusaka in next 6 months
  • No access to a telephone
  • Actively suicidal or alcohol intoxication and in need of immediate care
  • Currently psychotic
  • Participating in another interventional study that would interfere with participation

Who the study is looking for

  • 18 years of age or older
  • Living with HIV
  • Receiving HIV care at study site
  • Hazardous alcohol use plus at least one mental health or other substance use comorbidity or moderate to severe alcohol use disorder regardless of comorbidity
  • 6 months since initiation of Antiretroviral Treatment (ART)
  • Suboptimal HIV care outcome based on at least 1 of the following occurences in the past year: Late (at least 14 days from scheduled) Antiretroviral Treatment (ART) drug pick up, HIV viral load (VL) above the limit of assay detection, or referral to enhanced adherence

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kalingalinga Health Centre
Coordinator of this site? Confirm its status
LusakaZambiaUnknown status
Mtendere health centre
Coordinator of this site? Confirm its status
LusakaZambiaUnknown status
Ngombe health centre
Coordinator of this site? Confirm its status
LusakaZambiaUnknown status
Chilenje Level 1 Hospital
Coordinator of this site? Confirm its status
LusakaZambiaUnknown status
Kamwala Health Centre
Coordinator of this site? Confirm its status
LusakaZambiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.